Heterocylic compounds and methods of use

Details for Australian Patent Application No. 2002352073 (hide)

Owner Novartis AG

Inventors Stanton, James, Lawrence; Sabio, Michael, Lloyd; Vadananda, Thalaththani, Ralalage; Kapa, Prasad, Koteswara; Lee, George, Tien-San; Loeser, Eric, M.; Bach, Andrew, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2002352073

PCT Number PCT/EP02/13025

PCT Pub. Number WO2003/043985

Priority 60/396,906 18.07.02 US; 60/331,986 21.11.01 US

Filing date 20 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 19 October 2006

International Classifications

C07D 209/12 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/42 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/396,906 18.07.02 US; 60/331,986 21.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002352073

19 October 2006 Application Accepted

  Published as AU-B-2002352073

9 November 2006 Corrigenda

  Applications Accepted - Name Index Under the name Novartis AG, Application No. 2002352073, under INID (54) correct the title to read Heterocyclic compounds and methods of use. Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2001249912 Sherwood Services AG 2001291893 Gruenenthal GmbH 2002214111 Pierre Fabre Dermo-Cosmetique

1 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002352074-SYSTEM AND METHOD FOR CONTROLLING SPECTRAL PASSBAND PROFILE

2002352072-CONDITIONING SOLUTION FOR CONTACT LENSES